Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
The medical device reprocessing market is projected to reach USD 3.9 billion by 2027 from USD 2.0 billion in 2022, at a CAGR of 13.7% during the forecast period. Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.
To know about the assumptions considered for the study, Request for Free Sample Report
Medical Device Reprocessing Market Dynamics
Drivers: Increasing level of supply chain cost savings in healthcare facilities
Reprocessing of medical devices and equipment has gained a lot of attention in recent years, not just across healthcare facilities for saving millions of dollars annually, but among manufacturers who are seeing it as a means of achieving substantial competitive advantage. According to the Association of the Medical Devices Reprocessors (AMDR, US), on average, reprocessed medical devices are 30% to 50% cheaper than their new counterparts; due to this, medical device reprocessing has become one of the most adopted strategies for supply chain cost reduction among hospitals, surgical centers, and other healthcare facilities. This frees up funds for end users to hire additional staff, upgrade technologies, and enhance healthcare quality, among other improvements.
Restraints: Increasing risk of hospital acquired infections
Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities. HAIs are not observed at admission and are considered a major cause of morbidity and mortality worldwide. Despite the existence of reprocessing guidelines and advances in device reprocessing methods, inadequate reprocessing of medical devices contribute to a significant proportion of hospital-acquired infection, where 22% of all surgical site infections (SSIs), one of the most common types of HAIs cases, are related to equipment reprocessing.
Opportunities: Regulatory changes favoring adoption of medical device reprocessing
Changing dynamics in a number of countries, such as France, Japan, and the Middle East & Africa, are expected to provide significant growth opportunities for medical device reprocessing. According to the AMDR, Japan is the most recent country to take steps to give hospitals access to remanufactured (commercially reprocessed) single-use medical devices. AMDR sees this as a major development for the global remanufacturing medical device industry, as Japan joins the growing number of countries that are adopting a clear regulatory path for remanufactured single-use devices. Thus, the emergence of regulatory guidelines for reprocessing medical devices in these countries provides significant opportunities for the players in this market to increase their geographic presence and garner a larger share in the medical device reprocessing market in the future.
Challenges: Stringent regulatory procedures for reprocessed medical devices
Reprocessed medical devices should comply with all the standards applicable to a new medical device. The guidelines on reprocessing medical devices do not differentiate between single-use and multi-use medical devices and require the same high standards for both. The safety and performance of the reprocessed device must be equivalent to the original device and must comply with the regulatory standards for medical devices stated in the FDA and EU regulations to receive 510K approval or ISO/CE certifications for marketing in North America and Europe. The pressure to comply with these stringent regulations while reprocessing medical devices serves as a major challenge to the growth of the medical device reprocessing market.
The reprocessed support and services segment is expected to have the highest CAGR during the forecast period
Based on type, the medical device reprocessing market is segmented into reprocessing support & services and reprocessed medical devices. Reprocessing support & services segment is expected to register the highest growth during the forecast period. This is mainly due to the increasing adoption of third party reprocessing services by healthcare facilities to reduce in-house reprocessing costs.
Critical devices segment accounted for the largest share of the medical device reprocessing market in 2021
Based on the device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The rising number of cardiac diseases and their diagnosis globally, as well as the adoption of reprocessed catheters, have further increased as a means to reduce hospital and procedure costs, thereby, driving the market growth.
The cardiology segment accounted for the largest share of the medical device reprocessing market in 2021
Based on application, the medical device reprocessing market is segmented into cardiology, gastroenterology, gynecology, arthroscopy and orthopedic surgery, general surgery & anesthesia, and other applications (urology, non-invasive surgeries, and patient monitoring). The cardiology segment accounted for the largest share of the global medical device reprocessing market in 2021. This can be attributed to the increasing prevalence of cardiac diseases leading to higher demand for diagnostic and cardiac procedures. The increasing diagnostic and surgical procedures in the specialty area is thereby responsible for the adoption of reprocessed medical devices, as a means to reduce costs associated with buying new device for every new procedure.
Asia Pacific segment is expected to register the highest CAGR during the forecast period
North America accounted for the largest share of the medical device reprocessing market in 2021. However, the medical device reprocessing market in the Asia Pacific is expected to register the highest growth during the forecast period. This can be attributed to the growing economy, the increasing prevalence of chronic diseases, and the growing need to reduce hospital costs.
To know about the assumptions considered for the study, download the pdf brochure
Medical Device Reprocessing Market Key Players
The prominent players in the medical device reprocessing market include Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2020–2027 |
|
Base year considered |
2021 |
|
Forecast period |
2022–2027 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Type, Device Category, and Application |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
|
Companies covered |
Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US), SureTek Medical (US), Konoike Group (Japan), Avante Health Solutions (US), Medsalv (New Zealand), and Vitruvia Medical AG (Switzerland). |
The study categorizes the Medical Device Reprocessing Market based on type, device category, application, and regional level.
By Type
- Reprocessing Support & Services
- Reprocessed medical devices
By Device Category
- Critical Devices
- Semi- Critical Devices
- Non- Critical Devices
By Application
- Cardiology
- Gastroenterology
- Gynecology
- Arthroscopy & Orthopedic Surgery
- General Surgery and Anesthesia
- Other Applications (Urology, non-invasive surgeries, patient monitoring)
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Australia
- Japan
- China
- India
- Rest of APAC
- Latin America
- Middle East & Africa
Recent Developments
- In 2022, Innovative Health, LLC has received clearance to reprocess the Philips Eagle Eye Platinum digital IVUS (intravascular ultrasound) catheter. This clearance effectively marks the company’s entry into the cath lab space, thereby expanding the company’s medical device reprocessing market reach in cardiology applications.
- In 2022, Medline ReNewal opened a new distribution center in Southaven, Mississippi. The facility serves major hospitals, nursing homes, and military facilities in the region. The company invested in expanding its storage and distribution capacity in Mississippi to meet the product needs of its healthcare customers. Over USD 350.0 million in annual orders are expected to be handled from the Southaven facility.
- In 2021, a group of private equity giants acquired Medline industries for more than USD 30 billion. However, even after the transaction, Medline remained a privately-held company.
- In 2021, Innovative Health, LLC announced the opening of its new Research & Innovation Center, which will focus on expanding the power of reprocessing into new therapeutic areas and device technologies. With a focus on technology and innovation, the company aims to enhance its current medical device reprocessing technology and expand its service portfolio in various therapeutic application areas.
- In 2020, Northeast Scientific Inc. received the FDA clearance for reprocessing the .014 Digital IVUS catheter. With this clearance, the company was able to add the 0.14 Digital IVUS catheter to its existing portfolio of reprocessed medical devices.
Frequently Asked Questions (FAQ):
Which are the top industry players in the medical device reprocessing market?
The top market players in the global medical device reprocessing market include Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), and Cardinal Health (Sustainable Technologies) (US).
Which global medical device reprocessing services have been included in this report?
This report contains the following main segments:
- Reprocessing support & services
- Reprocessed medical devices
Which geographical region is dominating the global medical device reprocessing market?
The global medical device reprocessing market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest share of the medical device reprocessing market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North America has the larger share in the medical device reprocessing market due to factors such as favorable regulatory standards increasing the adoption of reprocessed medical devices by healthcare providers, and the increasing need to reduce hospital costs.
Which is the leading reprocessed medical device?
Based on device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The growth of this segment is mainly attributed to the rising number of hospital admissions and surgical procedures, leading to an increased use of reprocessed critical devices that costs less than purchasing a new device. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 22)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 26)
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS
2.4 DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET
3 EXECUTIVE SUMMARY (Page No. - 39)
FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET
4 PREMIUM INSIGHTS (Page No. - 43)
4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET
FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE HEALTHCARE COSTS TO DRIVE MARKET
4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021)
FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020–2027)
FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 47)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing level of supply chain cost savings in healthcare facilities
5.2.1.2 Growing adoption of strategies for sustainability and environmental safety
TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING
5.2.1.3 Rising geriatric population
FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS
5.2.2 RESTRAINTS
5.2.2.1 Increasing risk of hospital-acquired infections among patients
5.2.2.2 Increasing number of medical device surface alterations due to reprocessing
TABLE 5 IMPACT ANALYSIS: RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.3.1 Regulatory changes favoring adoption of medical device reprocessing
5.2.3.2 Growing opportunities and favorable regulations in developing countries
TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory procedures for reprocessed medical devices
TABLE 7 IMPACT ANALYSIS: CHALLENGES
5.3 KEY CONFERENCES AND EVENTS
TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.4 INDUSTRY TRENDS
5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH THROUGH ACQUISITIONS
TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET
5.4.2 SPECIALTY REPROCESSING
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT FROM NEW ENTRANTS
5.5.2 THREAT FROM SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
5.7.1.2 Canada
5.7.2 EUROPE
TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING
5.7.3 ASIA PACIFIC
5.7.3.1 Japan
5.7.3.2 Australia
5.7.3.3 Rest of Asia Pacific
TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING
5.8 TECHNOLOGY ANALYSIS
TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE REPROCESSING MARKET
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET
5.10 ECOSYSTEM ANALYSIS
FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING
FIGURE 26 PATENT PUBLICATION TRENDS (2011–JULY 2022)
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011–JULY 2022)
FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011–JULY 2022)
TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021–2022
5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET
6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE (Page No. - 69)
6.1 INTRODUCTION
TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 REPROCESSING SUPPORT AND SERVICES
6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET
TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 REPROCESSED MEDICAL DEVICES
6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER COSTS TO DRIVE MARKET
TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS
TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE (Page No. - 75)
7.1 INTRODUCTION
TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
7.2 CRITICAL DEVICES
7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET
TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY
TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SEMI-CRITICAL DEVICES
7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 NON-CRITICAL DEVICES
7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET
TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION (Page No. - 81)
8.1 INTRODUCTION
TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 CARDIOLOGY
8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET
TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 GASTROENTEROLOGY
8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS TO DRIVE MARKET
TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY
8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET
TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING
TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 GYNECOLOGY
8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET
TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.6 GENERAL SURGERY
8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET
TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (Page No. - 90)
9.1 INTRODUCTION
FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021)
TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Presence of major players and healthcare cost reduction strategies to drive market
FIGURE 31 US: TOTAL NUMBER OF HOSPITALS
TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing geriatric population and increasing chronic diseases to drive market
TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Government initiatives and well-established standards to drive market
TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing hospital admissions to drive market
TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Growing diagnostic medical device market with rising chronic diseases to propel market
TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing use of diagnostic devices and government initiatives to drive market
TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing focus on reducing hospital costs to drive market
TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT
TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.1 AUSTRALIA
9.4.1.1 Growing adoption of medical devices for diagnosis and treatment to drive market
TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Regulatory reforms and need to reduce hospital costs to drive market
TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Government initiatives and developing economy to drive market
TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Government initiatives for diagnosis and treatment to drive market
TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE 2020–2027 (USD MILLION)
TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET
TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET
TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 126)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL DEVICE REPROCESSING MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE REPROCESSING MARKET
10.4 MARKET SHARE ANALYSIS, 2021
FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021
TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE BENCHMARKING
TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS
10.6 COMPANY FOOTPRINT
TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET
TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES)
TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES)
TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES)
10.7 COMPANY EVALUATION QUADRANT
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE PLAYERS
10.7.4 PARTICIPANTS
FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021)
10.8 COMPETITIVE SCENARIO
10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS
10.8.2 DEALS
10.8.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 140)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER CORPORATION
TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021)
11.1.2 JOHNSON & JOHNSON
TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW
FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
11.1.3 MEDTRONIC PLC
TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.4 STERIS HEALTHCARE
TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW
FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021)
11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES)
TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.6 ARJO GROUP (RENU MEDICAL, INC.)
TABLE 105 ARJO GROUP: COMPANY OVERVIEW
FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021)
11.1.7 VANGUARD AG
TABLE 106 VANGUARD AG: COMPANY OVERVIEW
11.1.8 MEDLINE RENEWAL
TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW
11.1.9 INNOVATIVE HEALTH
TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW
11.1.10 STERIPRO CANADA, INC
TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW
11.1.11 NORTHEAST SCIENTIFIC, INC.
TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW
11.2 OTHER PLAYERS
11.2.1 SURETEK MEDICAL
11.2.2 KONOIKE GROUP
11.2.3 AVANTE HEALTH SOLUTIONS
11.2.4 MEDSALV
11.2.5 VITRUVIA MEDICAL AG
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 169)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global medical device reprocessing market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply side and other participants were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the medical device reprocessing industry. The primary sources from the other participants group including hospital personnel, C-level executives, department heads, hospital directors, and long-term care center personnel. And others including, private consultants, contract manufacturers, suppliers, distributers and officials from government regulatory bodies.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, device type, application, and region).
Data Triangulation
After arriving at the market size, the total medical device reprocessing market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the medical device reprocessing market by type, device type, application and by region.
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall medical device reprocessing market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the medical device reprocessing market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the medical device reprocessing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, FDA approvals, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the medical device reprocessing market
- To benchmark players within the medical device reprocessing market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and service offering
- To evaluate and analyze the overall impact of COVID-19 on the medical device reprocessing market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Geographic Analysis
- Further breakdown of the Rest of Europe medical device reprocessing market into Switzerland, Russia, the Netherlands, Portugal, Poland, and Belgium
- Further breakdown of the Latin America medical device reprocessing market into Brazil, Mexico, and others.
Generating Response ...
Growth opportunities and latent adjacency in Medical Device Reprocessing Market